FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

4710411000001103: FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1287791000001118 FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1287801000001119 FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
26375901000001116 FemSeven Sequi Phase 2 patches (Merck Pharmaceuticals) 6 patch (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26376001000001113 FemSeven Sequi Phase 2 patches (Merck Pharmaceuticals) 6 patch en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
47207701000001114 FemSeven Sequi Phase 2 patches (Merck Serono Ltd) 6 patch en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
70538001000001112 FemSeven Sequi Phase 2 patches (Teva UK Ltd) 6 patch en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Is a Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches 6 patch true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Is pack of FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has active ingredient Levonorgestrel false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has manufactured dose form Prolonged-release transdermal patch false Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has AMP FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start